239 related articles for article (PubMed ID: 28144040)
1. Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci.
Szűcs Z; Bereczki I; Csávás M; Rőth E; Borbás A; Batta G; Ostorházi E; Szatmári R; Herczegh P
J Antibiot (Tokyo); 2017 May; 70(5):664-670. PubMed ID: 28144040
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Velogene genomic assay for detection of vanA and vanB genes in vancomycin-resistant Enterococcus species.
Appleman MD; Citron DM; Kwok R
J Clin Microbiol; 2004 Apr; 42(4):1751-2. PubMed ID: 15071039
[TBL] [Abstract][Full Text] [Related]
3. Emergence of vanA Genotype Vancomycin-Resistant Enterococci with Low or Moderate Levels of Teicoplanin Resistance in Korea.
Eom JS; Hwang IS; Hwang BY; Lee JG; Lee YJ; Cheong HJ; Park YH; Park SC; Kim WJ
J Clin Microbiol; 2004 Apr; 42(4):1785-6. PubMed ID: 15071050
[TBL] [Abstract][Full Text] [Related]
4. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
Streit JM; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
[TBL] [Abstract][Full Text] [Related]
5. Rapid detection and differentiation method of VanA, VanB and VanC phenotypes in vancomycin-resistant enterococci.
Hanaki H; Yamaguchi Y; Nomura S; Nagayama A; Sunakawa K
Int J Antimicrob Agents; 2004 May; 23(5):502-5. PubMed ID: 15120731
[TBL] [Abstract][Full Text] [Related]
6. New semisynthetic glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococci.
Malabarba A; Ciabatti R; Scotti R; Goldstein BP; Ferrari P; Kurz M; Andreini BP; Denaro M
J Antibiot (Tokyo); 1995 Aug; 48(8):869-83. PubMed ID: 7592033
[TBL] [Abstract][Full Text] [Related]
7. Specificity of induction of the vanA and vanB operons in vancomycin-resistant enterococci by telavancin.
Hill CM; Krause KM; Lewis SR; Blais J; Benton BM; Mammen M; Humphrey PP; Kinana A; Janc JW
Antimicrob Agents Chemother; 2010 Jul; 54(7):2814-8. PubMed ID: 20404117
[TBL] [Abstract][Full Text] [Related]
8. vanA Gene Harboring Enterococcal and Non-enterococcal Isolates Expressing High Level Vancomycin and Teicoplanin Resistance Reservoired in Surface Waters.
Nakipoğlu M; Yilmaz F; Icgen B
Bull Environ Contam Toxicol; 2017 May; 98(5):712-719. PubMed ID: 27770152
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.
van Den Braak N; Goessens W; van Belkum A; Verbrugh HA; Endtz HP
J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798
[TBL] [Abstract][Full Text] [Related]
10. [Phenotypic and genotypic traits of vancomycin-resistant enterococci in a public hospital: the first vanB-positive Enterococcus faecium isolates].
Coşkun FA; Mumcuoğlu I; Aksu N; Karahan ZC; Us E; Tekeli FA; Baran I; Kanyılmaz D; Kurşun S
Mikrobiyol Bul; 2012 Apr; 46(2):276-82. PubMed ID: 22639316
[TBL] [Abstract][Full Text] [Related]
11. Detection and genetic characterisation of vanA-containing Enterococcus strains in healthy Lusitano horses.
Moura I; Radhouani H; Torres C; Poeta P; Igrejas G
Equine Vet J; 2010 Mar; 42(2):181-3. PubMed ID: 20156257
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
[TBL] [Abstract][Full Text] [Related]
13. vanA-containing Enterococcus faecium susceptible to vancomycin and teicoplanin because of major nucleotide deletions in Tn1546.
Gagnon S; Lévesque S; Lefebvre B; Bourgault AM; Labbé AC; Roger M
J Antimicrob Chemother; 2011 Dec; 66(12):2758-62. PubMed ID: 21926081
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an Enterococcus gallinarum Isolate Carrying a Dual vanA and vanB Cassette.
Eshaghi A; Shahinas D; Li A; Kariyawasam R; Banh P; Desjardins M; Melano RG; Patel SN
J Clin Microbiol; 2015 Jul; 53(7):2225-9. PubMed ID: 25948610
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype.
Song JH; Ko KS; Suh JY; Oh WS; Kang CI; Chung DR; Peck KR; Lee NY; Lee WG
J Antimicrob Chemother; 2008 Apr; 61(4):838-44. PubMed ID: 18230690
[TBL] [Abstract][Full Text] [Related]
16. Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistance.
Hashimoto Y; Tanimoto K; Ozawa Y; Murata T; Ike Y
FEMS Microbiol Lett; 2000 Apr; 185(2):247-54. PubMed ID: 10754256
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.
Kolár M; Vágnerová I; Látal T; Kohnová I
Acta Univ Palacki Olomuc Fac Med; 1999; 142():69-71. PubMed ID: 10743728
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function.
Szűcs Z; Csávás M; Rőth E; Borbás A; Batta G; Perret F; Ostorházi E; Szatmári R; Vanderlinden E; Naesens L; Herczegh P
J Antibiot (Tokyo); 2017 Feb; 70(2):152-157. PubMed ID: 27353163
[TBL] [Abstract][Full Text] [Related]
19. Glycopeptide-resistance transferability from vancomycin-resistant enterococci of human and animal source to Listeria spp.
de Niederhäusern S; Sabia C; Messi P; Guerrieri E; Manicardi G; Bondi M
Lett Appl Microbiol; 2004; 39(6):483-9. PubMed ID: 15548299
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-susceptible dairy and clinical enterococcal isolates carry vanA and vanB genes.
Ribeiro T; Abrantes M; Lopes Mde F; Crespo MT
Int J Food Microbiol; 2007 Feb; 113(3):289-95. PubMed ID: 17140688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
